DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka

Country: 🇱🇰Sri Lanka

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

Phase 1

Completed

Conditions: Fasting

Interventions: Drug: Amlodipine Besylate/Benazepril HCl

First Posted Date: 2012-01-09

Last Posted Date: 2012-01-09

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 50

Registration Number: NCT01506011

Locations: 🇮🇳
Vimta Labs Ltd., Hyderabad, A.P, India

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Phase 1

Completed

Conditions: Fed

Interventions: Drug: Amlodipine Besylate/Benazepril HCl

First Posted Date: 2012-01-09

Last Posted Date: 2012-01-09

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 49

Registration Number: NCT01505998

Locations: 🇮🇳
Vimta Labs Ltd., Hyderabad, A.P, India

Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Aricept
Drug: Donepezil Hydrochloride

First Posted Date: 2012-01-05

Last Posted Date: 2012-01-06

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 25

Registration Number: NCT01504516

Locations: 🇮🇳
Bioserve Clinical Research Private Limited, Hyderabad, Andhra Pradesh, India

Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Donepezil Hydrochloride
Drug: Aricept

First Posted Date: 2012-01-05

Last Posted Date: 2012-01-06

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 26

Registration Number: NCT01504503

Locations: 🇮🇳
Bioserve Clinical Research Private Limited, Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Phase 1

Completed

Conditions: Fasting

Interventions: Drug: Olanzapine OD Tablets 5 mg

First Posted Date: 2012-01-04

Last Posted Date: 2012-01-05

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 22

Registration Number: NCT01503437

Locations: 🇮🇳
Wellquest Clinical Research, Mumbai, Maharashtra, India

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

Phase 1

Completed

Conditions: Fed

Interventions: Drug: Olanzapine

First Posted Date: 2012-01-04

Last Posted Date: 2012-01-05

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT01503424

Locations: 🇮🇳
Lambda Therapeutic Research Ltd.,, Ahmedabad, Gujrat, India

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Phase 1

Completed

Conditions: Fed

Interventions: Drug: Olanzapine OD Tablets 5 mg

First Posted Date: 2012-01-04

Last Posted Date: 2012-01-05

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 26

Registration Number: NCT01503450

Locations: 🇮🇳
Wellquest Clinical Research, Mumbai, Maharashtra, India

Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

Phase 1

Completed

Conditions: Fasting

Interventions: Drug: Olanzapine

First Posted Date: 2012-01-04

Last Posted Date: 2012-01-05

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 48

Registration Number: NCT01503398

Locations: 🇮🇳
Lambda Therapeutic Research Ltd.,, Ahmedabad, Gujrat, India

DFA-02 in Patients Undergoing Colorectal Surgery

Phase 1

Completed

Conditions: Surgical Site Infection

Interventions: Drug: DFA-02
Drug: Placebo

First Posted Date: 2011-12-21

Last Posted Date: 2014-09-01

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 30

Registration Number: NCT01496352

A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels

Phase 2

Completed

Conditions: Type II Hyperlipidemia

Interventions: Drug: DRL-17822 or placebo

First Posted Date: 2011-07-07

Last Posted Date: 2014-04-22

Lead Sponsor: Dr. Reddy's Laboratories Limited

Target Recruit Count: 176

Registration Number: NCT01388816

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy